484 related articles for article (PubMed ID: 12853195)
1. Decline in the AIDS and death rates in the EuroSIDA study: an observational study.
Mocroft A; Ledergerber B; Katlama C; Kirk O; Reiss P; d'Arminio Monforte A; Knysz B; Dietrich M; Phillips AN; Lundgren JD;
Lancet; 2003 Jul; 362(9377):22-9. PubMed ID: 12853195
[TBL] [Abstract][Full Text] [Related]
2. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
3. AIDS across Europe, 1994-98: the EuroSIDA study.
Mocroft A; Katlama C; Johnson AM; Pradier C; Antunes F; Mulcahy F; Chiesi A; Phillips AN; Kirk O; Lundgren JD
Lancet; 2000 Jul; 356(9226):291-6. PubMed ID: 11071184
[TBL] [Abstract][Full Text] [Related]
4. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
Gandhi T; Wei W; Amin K; Kazanjian P
Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
[TBL] [Abstract][Full Text] [Related]
5. [Decline in AIDS and death rates in the EuroSIDA study. An observational study].
Kirk O; Mocroft A; Lundgren JD;
Ugeskr Laeger; 2004 Jun; 166(26-31):2572-6. PubMed ID: 15285167
[No Abstract] [Full Text] [Related]
6. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004.
Schneider MF; Gange SJ; Williams CM; Anastos K; Greenblatt RM; Kingsley L; Detels R; Muñoz A
AIDS; 2005 Nov; 19(17):2009-18. PubMed ID: 16260908
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression.
Jacobson LP; Li R; Phair J; Margolick JB; Rinaldo CR; Detels R; Muñoz A
Am J Epidemiol; 2002 Apr; 155(8):760-70. PubMed ID: 11943695
[TBL] [Abstract][Full Text] [Related]
8. Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002.
Chan KC; Wong KH; Lee SS
HIV Med; 2006 Apr; 7(3):186-92. PubMed ID: 16494633
[TBL] [Abstract][Full Text] [Related]
9. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
[TBL] [Abstract][Full Text] [Related]
10. The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy.
d'Arminio Monforte A; Sabin CA; Phillips A; Sterne J; May M; Justice A; Dabis F; Grabar S; Ledergerber B; Gill J; Reiss P; Egger M;
Arch Intern Med; 2005 Feb; 165(4):416-23. PubMed ID: 15738371
[TBL] [Abstract][Full Text] [Related]
11. AIDS incidence and mortality in a hospital-based cohort of HIV-1-seropositive patients receiving highly active antiretroviral therapy in São Paulo, Brazil.
Casseb J; Fonseca LA; Veiga AP; de Almeida A; Bueno A; Ferez AC; Gonsalez CR; Brigido LF; Mendonça M; Rodrigues R; Santos N; Malacarne E; Ronchini KO; Zihlmann KF; Duarte AJ
AIDS Patient Care STDS; 2003 Sep; 17(9):447-52. PubMed ID: 14588082
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.
Weverling GJ; Mocroft A; Ledergerber B; Kirk O; Gonzáles-Lahoz J; d'Arminio Monforte A; Proenca R; Phillips AN; Lundgren JD; Reiss P
Lancet; 1999 Apr; 353(9161):1293-8. PubMed ID: 10218526
[TBL] [Abstract][Full Text] [Related]
13. Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies.
Chêne G; Sterne JA; May M; Costagliola D; Ledergerber B; Phillips AN; Dabis F; Lundgren J; D'Arminio Monforte A; de Wolf F; Hogg R; Reiss P; Justice A; Leport C; Staszewski S; Gill J; Fatkenheuer G; Egger ME;
Lancet; 2003 Aug; 362(9385):679-86. PubMed ID: 12957089
[TBL] [Abstract][Full Text] [Related]
14. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
Katsarou O; Touloumi G; Antoniou A; Kouramba A; Hatzakis A; Karafoulidou A
Haemophilia; 2005 Jul; 11(4):360-5. PubMed ID: 16011588
[TBL] [Abstract][Full Text] [Related]
15. Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3.
Lau B; Gange SJ; Moore RD
J Acquir Immune Defic Syndr; 2007 Feb; 44(2):179-87. PubMed ID: 17075385
[TBL] [Abstract][Full Text] [Related]
16. Predictors of AIDS-defining events among advanced naïve patients after HAART.
Torti C; Lapadula G; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Pietro MD; Migliorino G; Quiros-Roldan E; Ladisa N; Sighinolfi L; Gatti F; Carosi G;
HIV Clin Trials; 2007; 8(3):112-20. PubMed ID: 17621458
[TBL] [Abstract][Full Text] [Related]
17. Causes of death among people living with AIDS in the pre- and post-HAART Eras in the city of São Paulo, Brazil.
Domingues CS; Waldman EA
PLoS One; 2014; 9(12):e114661. PubMed ID: 25500837
[TBL] [Abstract][Full Text] [Related]
18. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy.
Kirk O; Pedersen C; Cozzi-Lepri A; Antunes F; Miller V; Gatell JM; Katlama C; Lazzarin A; Skinhøj P; Barton SE;
Blood; 2001 Dec; 98(12):3406-12. PubMed ID: 11719381
[TBL] [Abstract][Full Text] [Related]
19. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
20. Thrush and fever as markers of immune competence in the era of highly active antiretroviral therapy.
Skolasky RL; Phair J; Detels R; Riddler S; Margolick J; Jacobson LP
AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1311-6. PubMed ID: 11602040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
